Hotchkis & Wiley Capital Management LLC cut its holdings in shares of Proto Labs, Inc. (NYSE:PRLB - Free Report) by 53.2% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 152,100 shares of the industrial products company's stock after selling 173,020 shares during the quarter. Hotchkis & Wiley Capital Management LLC owned 0.64% of Proto Labs worth $5,330,000 at the end of the most recent reporting period.
A number of other institutional investors also recently bought and sold shares of PRLB. LPL Financial LLC purchased a new stake in Proto Labs in the 4th quarter worth $210,000. Wells Fargo & Company MN boosted its position in shares of Proto Labs by 23.3% during the 4th quarter. Wells Fargo & Company MN now owns 15,199 shares of the industrial products company's stock valued at $594,000 after acquiring an additional 2,869 shares during the last quarter. Barclays PLC boosted its position in shares of Proto Labs by 4.1% during the 4th quarter. Barclays PLC now owns 44,393 shares of the industrial products company's stock valued at $1,735,000 after acquiring an additional 1,760 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in Proto Labs by 5.5% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,300,864 shares of the industrial products company's stock valued at $50,851,000 after buying an additional 68,006 shares during the period. Finally, Aquatic Capital Management LLC lifted its position in Proto Labs by 18.2% in the fourth quarter. Aquatic Capital Management LLC now owns 8,981 shares of the industrial products company's stock valued at $351,000 after buying an additional 1,381 shares during the last quarter. 84.54% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of research analysts have commented on PRLB shares. Cantor Fitzgerald upped their target price on shares of Proto Labs from $50.00 to $51.00 and gave the company an "overweight" rating in a research report on Friday, August 1st. Craig Hallum raised shares of Proto Labs from a "hold" rating to a "buy" rating and set a $54.00 target price on the stock in a research report on Friday, August 1st. Finally, Wall Street Zen raised shares of Proto Labs from a "buy" rating to a "strong-buy" rating in a research report on Saturday, August 2nd. Two investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, Proto Labs presently has a consensus rating of "Moderate Buy" and an average target price of $52.50.
Get Our Latest Research Report on PRLB
Insiders Place Their Bets
In other news, CEO Suresh Krishna bought 1,725 shares of Proto Labs stock in a transaction that occurred on Monday, August 4th. The shares were purchased at an average price of $43.51 per share, with a total value of $75,054.75. Following the completion of the acquisition, the chief executive officer directly owned 18,021 shares in the company, valued at $784,093.71. The trade was a 10.59% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 1.20% of the stock is currently owned by company insiders.
Proto Labs Price Performance
Shares of NYSE PRLB traded down $1.08 during midday trading on Friday, hitting $49.69. The company's stock had a trading volume of 207,182 shares, compared to its average volume of 185,243. The business's fifty day simple moving average is $43.29 and its two-hundred day simple moving average is $39.47. Proto Labs, Inc. has a 1 year low of $26.34 and a 1 year high of $51.09. The firm has a market capitalization of $1.19 billion, a price-to-earnings ratio of 82.81 and a beta of 1.27.
Proto Labs (NYSE:PRLB - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The industrial products company reported $0.41 EPS for the quarter, beating the consensus estimate of $0.33 by $0.08. Proto Labs had a net margin of 2.91% and a return on equity of 2.22%. The business had revenue of $135.06 million during the quarter, compared to analyst estimates of $128.05 million. During the same quarter last year, the firm posted $0.38 earnings per share. The business's revenue for the quarter was up 7.6% compared to the same quarter last year. Proto Labs has set its Q3 2025 guidance at 0.350-0.430 EPS. Analysts anticipate that Proto Labs, Inc. will post 0.81 EPS for the current fiscal year.
Proto Labs Profile
(
Free Report)
Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.
Further Reading

Before you consider Proto Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Proto Labs wasn't on the list.
While Proto Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.